DexCom, Inc. reported Q4 2025 revenue of $1.260 billion, up 13% year-over-year, GAAP operating income of $323.0 million (25.6% of revenue), and full-year 2025 revenue of $4.662 billion, up 16%. The company reiterated 2026 revenue guidance of $5.16-$5.25 billion and highlighted launches of Dexcom G7 15 Day CGM and Dexcom Smart Basal.